The National Institute for Health and Care Excellence (NICE) has recommended degarelix (marketed as 'Firmagon') for a group of men with advanced hormone-dependent prostate cancer – those with spinal metastases. This announcement comes after a review...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/297TMvn
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Purpose: The MHC-unrestricted activity of cytokine-induced killer (CIK) cells against chemo-surviving melanoma cancer stem cells (mCSC) was...
-
Induced overexpression of CD44 associated with resistance to apoptosis on DNA damage response in human head and neck squamous cell carc...
-
9780275967376 0275967379 Realism and American Foreign Policy - Wilsonians and the Kennan-Morgenthau Thesis, Steven J. Bucklin Vin Diesel, Pa...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου